Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LORAMIDE CAPSULE 2 MG - HSA Drug Approval Details

Approvals/HSA/LORAMIDE CAPSULE 2 MG

Approved

THERAPEUTIC

LORAMIDE CAPSULE 2 MG

Y S P INDUSTRIES (M) SDN BHD (MALAYSIA)🇸🇬 Health Sciences Authority

Approval Date: Feb 20, 1997
Approval ID: 19548cc40e458ef1
Company: Y S P INDUSTRIES (M) SDN BHD (MALAYSIA)
Type: Therapeutic

Approval Details

Approval Id: 19548cc40e458ef1
Drug Name: LORAMIDE CAPSULE 2 MG
Product Name: LORAMIDE CAPSULE 2 MG
Approval Number: SIN09217P
Approval Date: 1997-02-20
Registrant: YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence Holder: YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: PHARMACY ONLY MEDICINES
Dosage Form: CAPSULE
Route Of Administration: ORAL
Atc Code: A07DA03
Atc Item Name: loperamide
Pharma Manufacturer Name: YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Active Ingredients

LOPERAMIDE HCl

2 mg

LOPERAMIDE HCl

2 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Feb 20, 1997

Approval ID

19548cc40e458ef1

Type

Therapeutic

Back to HSA Approvals